Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Ayurvedic treatment improved symptoms and reduced TSH levels in a hypothyroidism patient.

Lower LDL-c levels predict higher COVID-19 mortality.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Both drugs lower DHT levels, with GI198745 being more effective.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

A blood pressure drug, diltiazem, may also help treat influenza.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.